Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1167363

	registered interest
	date	30/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Digital Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, who is responsible for digitisation in his Department; and what mechanisms the person with responsibility for digitisation uses to champion digitisation.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	7664
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>The Government Digital Service leads the Government’s digital, data and technology function. Responsibility for digitisation within the Department is discharged by the Chief Executive Officer (CEO) of NHSX. NHSX is a joint unit between the Department and NHS England and NHS Improvement, and launched on 1 July this year.</p><p> </p><p>The CEO has system-wide responsibility for digital and technology policy in health and social care, and is both a Director General in the Department and National Director for Digital in NHS England. The organisation combines the levers of policy and implementation, including setting of national strategy, delivery of programmes, development of best practice, and setting of standards. Departmental officials within NHSX are also responsible for overseeing NHS Digital.</p><p> </p><p>The current CEO is Matthew Gould.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 05/11/2019 13:03:31 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	1439 label Biography information for Norman Lamb

1166899

	registered interest
	date	28/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress has been made on (a) the NHS Long Term Plan commitment to ensure that 100 per cent of children and young people who need specialist mental health care can access it and (b) ensuring that 100 per cent of children aged 2 and under can access that care.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	6260
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 05/11/2019 16:55:53 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	1439 label Biography information for Norman Lamb

1166900

	registered interest
	date	28/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps the Government is taking to fulfill its commitment in its Prevention Green Paper to seek views on how to improve the healthy social and emotional development of babies and young children.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	6261
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>The Government is taking steps to fulfil its commitment in its Prevention Green Paper to seek views on how to improve the healthy social and emotional development of babies and young children.</p><p>Public Health England’s (PHE’s) vision is to improve the health of babies, children and their families and to enable the foundations of good health into adulthood. A large proportion of this work will be done through the modernisation of the Healthy Child Programme, which is PHE’s national offer to our children and families. This can be viewed at the following links:</p><p> </p><p><a href="https://www.gov.uk/government/publications/healthy-child-programme-pregnancy-and-the-first-5-years-of-life" target="_blank">https://www.gov.uk/government/publications/healthy-child-programme-pregnancy-and-the-first-5-years-of-life</a></p><p><a href="https://www.gov.uk/government/publications/healthy-child-programme-5-to-19-years-old" target="_blank">https://www.gov.uk/government/publications/healthy-child-programme-5-to-19-years-old</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/11/2019 12:02:19 answering member 4380 label Biography information for Jo Churchill
	tabling member	1439 label Biography information for Norman Lamb

1166901

	registered interest
	date	28/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health: Children
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he is putting in place to support and monitor the delivery of the revised Healthy Child programme.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	6262
	answer	answer is ministerial correction date of answer 05/11/2019 answer text <p>It has not proved possible to respond to the hon. Member in the time available before Dissolution.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/11/2019 16:54:05 answering member 4380 label Biography information for Jo Churchill
	tabling member	1439 label Biography information for Norman Lamb

1150324

	registered interest
	date	17/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Disability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the risks posed to people living with disabilities by a lack of availability of (a) medicines and (b) essential medical equipment in the event of the UK leaving the EU without a withdrawal agreement.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	1607
	answer	answer is ministerial correction date of answer 22/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p>The Department, as part of our EU exit preparations, has analysed the supply chains of over 12,000 licensed medicines used by patients in the United Kingdom and close to half a million product lines of medical devices and clinical consumables with an EU/European Economic Area touchpoint. This approach means that the medicines and medical equipment used by people living with disabilities are included within our planning.</p><p>We continue to implement a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 22/10/2019 15:31:09 answering member 4362 label Biography information for Edward Argar
	tabling member	1439 label Biography information for Norman Lamb

1149333

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether anti-epileptic drugs are exempted from serious shortage protocols; and what assessment he has made of the potential effect of the use of such protocols on (a) people with learning disabilities and (b) their families in the event that the UK leaves the EU without a withdrawal agreement.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	475
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>While Serious Shortage Protocols (SSP) in England have the scope to cover all medicines and appliances that are on a National Health Service prescription in primary care, including anti-epileptic drugs, it is clear that an SSP for therapeutic or generic equivalents will not necessarily be suitable for all medicines and patients. For example, where medicines need to be prescribed by brand for clinical reasons, which is the case for epilepsy medication.</p><p>Any protocol would only be introduced if clinicians with expertise in the relevant area think it is appropriate. Pharmacists will have to use their professional judgment as to whether supplying against the protocol rather than the prescription is appropriate or the patient should be referred to their prescriber.</p><p>The legislation enabling Ministers to issue SSPs was not introduced as a European Union exit measure alone but as a business-as-usual measure that can be used before and after our exit from the EU.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/10/2019 13:07:33 answering member 4362 label Biography information for Edward Argar
	tabling member	1439 label Biography information for Norman Lamb

1149339

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Epilepsy: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the availability of anti-epilepsy medications in the event that the UK leaves the EU without a deal.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	479
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including those used for the treatment of epilepsy, once we have left the EU.</p><p>The Department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>We have been working closely with suppliers to monitor over 300 different epilepsy medicines provided by almost 50 companies and we are pleased to see many are holding stockpiles far beyond the six weeks’ additional buffer we requested. We also know that the vast majority of those suppliers with lower levels of stockpiles are taking action to re-route their supply chains away from the short straits crossings where applicable.</p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/10/2019 13:04:06 answering member 4362 label Biography information for Edward Argar
	tabling member	1439 label Biography information for Norman Lamb

1147165

	registered interest
	date	30/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Chief Scientific Advisers
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many meetings he had with his Department’s Chief Scientific Adviser from 1 June to 31 August 2019.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	292148
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>For the period 1 June 2019 to 31 August 2019 my Rt. Hon. Friend the Secretary of State for Health and Social Care met with the Department’s Chief Scientific Adviser (CSA) three times, the CSA met with other Health Ministers on seven occasions.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 08/10/2019 10:30:10 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1439 label Biography information for Norman Lamb

1143605

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial in BAME communities.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	285065
	answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 285069 question first answered 05/09/2019 15:28:31 answering member 4380 label Biography information for Jo Churchill
	tabling member	1439 label Biography information for Norman Lamb

1143606

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	HIV Infection: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) raise awareness of and (b) increase access to the PrEP impact trial amongst women at high risk of contracting HIV.
	tabling member constituency	North Norfolk
	tabling member printed	Norman Lamb
	uin	285069
	answer	answer is ministerial correction date of answer 05/09/2019 answer text <p>A core function of the pre-exposure prophylaxis (PrEP) Impact Trial Community Advisory Board (CAB) is to raise awareness and uptake of PrEP in key populations including women and black, Asian and minority ethnic (BAME) communities. Further information about PrEP Impact Trial CAB activities and participating community groups can be found at the following links:</p><p><a href="https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/" target="_blank">https://www.england.nhs.uk/commissioning/spec-services/npc-crg/blood-and-infection-group-f/f03/prep-trial-updates/</a></p><p><a href="https://www.prepimpacttrial.org.uk/faqs" target="_blank">https://www.prepimpacttrial.org.uk/faqs</a></p><p>In addition, Public Health England’s Innovation Fund has supported a number of community based projects aimed at increasing PrEP awareness in women, BAME groups and trans communities; information on the projects funded in 2018 can be found at the following links:</p><p><a href="https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018" target="_blank">https://www.gov.uk/government/news/innovative-hiv-prevention-projects-reached-170000-people-in-2018</a></p><p>Since the start of the PrEP Impact Trial in October 2017, over half of the available 26,000 trial places have been filled. As of 3 September 2019, all participating Trial clinics were open to recruitment for women, trans men and heterosexual men. Information on the enrolment status of participating clinics is regularly updated on the PrEP Impact Trial website at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 285065 question first answered 05/09/2019 15:28:31 answering member 4380 label Biography information for Jo Churchill
	tabling member	1439 label Biography information for Norman Lamb